BioSpace News Archive

CARsgen Therapeutics today announced that one of its leading drug candidates, humanized GPC3-CAR-T cell for the treatment of patients suffering from GPC3-positive solid tumors, has received Investigational New Drug (IND) clearance from the National Medical Products Administration (NMPA). This marks China’s first IND clearance for CAR-T cells against solid tumors.

2018 was another record-breaking year for Anne Arundel County, Maryland. In 2018, the County once again broke its own record for fatal opioid overdoses in a calendar year.

Created in collaboration with Apple, Attain by AetnaSM is a direct-to-member experience that blends activity-driven incentives and rewards with personalized health recommendations

Investment received from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket

New training for paramedics will increase access to palliative care in the home for patients and families, where they want it

410 Medical, Inc. today announced a recent publication in Journal of Infusion Nursing.

Duchesnay Inc. announced today that the FDA has approved its supplemental New Drug Application (sNDA) seeking to add moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy (VVA), due to menopause, to the indication of Osphena® (ospemifene).

Geyser Brands Inc. announces that the Company has planted it first crop under Heath Canada’s license to cultivate.

Valens GroWorks Corp. is pleased to announce that it has entered into a multi-year extraction services agreement (the “Agreement”) with Organigram Inc. (“Organigram”) (TSXV: OGI, OTC: OGRMF) for cannabis and hemp extraction services.

Old Pal has added three top executive leaders to its list of best in class new hires as they continue to position the company for unprecedented growth in 2019.